Click to search for your profile
Click to search for condition or expert
Click to open main menu
X-Linked Lymphoproliferative Disease Latest Advances
Find the latest research about X-Linked Lymphoproliferative Disease.
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Condition:
Adult-onset Primary Hemophagocytic Lymphohistiocytosis
Journal:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Treatment Used:
Haploidentical Hematopoietic Stem Cell Transplantation
Number of Patients:
15
Published —
July 14, 2020
The study researched the outcomes of haploidentical hematopoietic stem cell transplantation for adults with primary hemophagocytic lymphohistiocytosis.
Condition:
Acquired tumor-associated and primary pure red cell aplasia
Journal:
Annals of hematology
Treatment Used:
Immunosuppression therapy
Number of Patients:
12
Published —
June 04, 2020
The study researched the safety and effectiveness of immunosuppression therapy in patients with acquired tumor-associated and primary pure red cell aplasia.
Condition:
Lymphoproliferative Neoplasms
Journal:
Critical reviews in oncology/hematology
Treatment Used:
Fertility Preservation
Number of Patients:
0
Published —
June 03, 2020
This article reviews the gonadotoxic potential of classical chemotherapeutic treatments and novel targeted therapies for lymphoproliferative neoplasms in young patients to preserve and restore fertility after cancer healing.
Condition:
Atypical Lymphoid Hyperplasia in Patient with Severe Obstructive Sleep Apnea
Journal:
International journal of pediatric otorhinolaryngology
Treatment Used:
Tonsillectomy
Number of Patients:
1
Published —
May 04, 2020
This case report describes a 17 year-old female with severe sleep apnea undergoing tonsillectomy who was diagnosed with atypical lymphoid hyperplasia.
Condition:
Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System
Journal:
Viruses
Treatment Used:
Chemo-immunotherapy
Number of Patients:
1
Published —
April 12, 2020
This case report describes a patient with Epstein-Barr virus-induced post-transplant lymphoproliferative disorder of the central nervous system that was treated using chemo-immunotherapy.
Condition:
Epstein-Barr Virus-Associated Lymphoproliferative Disorder
Journal:
Cancer science
Treatment Used:
Alsterpaullone
Number of Patients:
0
Published —
November 20, 2019
This study tested the safety and efficacy of using alsterpaullone to treat patients with Epstein-Barr virus-associated lymphoproliferative disorders.
Condition:
Immune Thrombocytopenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Journal:
Blood
Treatment Used:
Eltrombopag
Number of Patients:
18
Published —
October 02, 2019
This study aimed to assess the safety and effectiveness of eltrombopag in patients with immune thrombocytopenia (ITP) secondary to chronic lymphoproliferative disorders (LPDs).
Condition:
Deficiency of Adenosine Deaminase 2 (DADA2) in Pediatric Patient with Chronic Lymphoproliferation and Cytopenia
Journal:
Pediatric hematology and oncology
Treatment Used:
Etanercept, Monthly Intravenous Immunoglobulin, and Low-Dose Methylprednisolone
Number of Patients:
1
Published —
September 17, 2019
This case report describes a pediatric patient diagnosed with deficiency of adenosine deaminase 2 (DADA2) treated with etanercept, monthly intravenous immunoglobulin replacement, and low-dose methylprednisolone.
Condition:
Epstein-Barr Virus Associated CNS Lymphoproliferative Disorder after Long-Term Immunosuppression
Journal:
Practical neurology
Treatment Used:
Mycophenolate Mofetil
Number of Patients:
1
Published —
August 31, 2019
This article reviews the role of mycophenolate mofetil in Epstein-Barr virus (EBV)-driven lymphoproliferative disorders, and discuss checking EBV status in all patients starting immunosuppression and in older people already taking immunosuppression.
Condition:
Castleman Disease of the Tonsil
Journal:
Diagnostic pathology
Treatment Used:
Local Removal
Number of Patients:
1
Published —
June 30, 2019
The study researched the outcomes of a patient with Castleman disease of the tonsil.
Condition:
B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities
Journal:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Treatment Used:
high-dose methylprednisolone with Rituximab and fresh frozen plasma (HDMP+RTX+FFP)
Number of Patients:
6
Published —
June 18, 2019
This study assessed whether high-dose methylprednisolone with rituximab and fresh frozen plasma (HDMP+RTX+FFP) for up to six cycles in improving outcomes for patients with B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities.
Condition:
Primary Cutaneous CD30+ Lymphoproliferative Disorders
Journal:
Blood
Treatment Used:
Skin-Directed and Systemic Therapies Monotherapy or Combination
Number of Patients:
0
Published —
June 06, 2019
This article discusses the treatment of primary cutaneous CD30+ lymphoproliferative disorders with skin-directed and systemic therapies monotherapy or combination.
Showing 1-12 of 17
Next